ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

CELL PhenomeX Inc

0,9981
0,00 (0,00%)
Nach Börsenschluss
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
PhenomeX Inc CELL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,9981 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,9981 0,9981
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.2.202423:58EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.10.202315:00EDGAR2Form 15-12G - Securities registration termination [Section..
03.10.202321:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202321:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202320:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.10.202323:16EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
02.10.202323:06EDGAR2Form S-8 POS - Securities to be offered to employees in..
02.10.202314:47EDGAR2Form 8-K - Current report
29.9.202314:30EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
27.9.202314:51PRNUSPhenomeX Announces Opto® Memory B Discovery Human Workflow..
21.9.202314:35PRNUSPhenomeX Announces the Release of SpotLight™ Human Lambda..
20.9.202314:48PRNUSPhenomeX to Participate in Upcoming Cell Biology Conferences
20.9.202312:05EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
15.9.202315:08PRNUSPhenomeX Unveils Meteor™ Chips For Quantitative Bulk..
05.9.202322:02PRNUSPhenomeX Inc. Announces Commencement of Cash Tender Offer by..
31.8.202322:47EDGAR2Form SC 14D9 - Solicitation, recommendation statements
28.8.202323:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18.8.202323:21EDGAR2Form SC14D9C - Written communication relating to third party..
17.8.202323:28EDGAR2Form SC14D9C - Written communication relating to third party..
17.8.202323:27EDGAR2Form 8-K - Current report
17.8.202315:10EDGAR2Form SC14D9C - Written communication relating to third party..
17.8.202315:09EDGAR2Form 8-K - Current report
17.8.202315:00BWBruker Corporation and PhenomeX Inc. Announce Definitive..
14.8.202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:09EDGAR2Form 8-K - Current report
14.8.202322:05PRNUSPhenomeX Reports Second Quarter 2023 Financial Results and..
09.8.202322:25PRNUSPhenomeX to Report Second Quarter 2023 Financial Results on..
07.8.202314:11PRNUSPhenomeX Announces Lifting of the Stay in AbCellera Patent..
28.7.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.7.202300:15EDGAR2Form 144 - Report of proposed sale of securities
07.7.202322:15EDGAR2Form 8-K - Current report
13.6.202315:32PRNUSPhenomeX's Beacon® Technology Enables Early Identification..
05.6.202314:46PRNUSPhenomeX Launches Beacon Quest™ Optofluidic System with..
15.5.202315:01PRNUSPhenomeX Launches Beacon Select™ Optofluidic System with..
11.5.202322:02PRNUSPhenomeX Reports First Quarter 2023 Financial Results
11.5.202315:35PRNUSPhenomeX To Participate in 19th Annual PEGS Boston..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock